相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242
I. Mancini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
Gernot Riedel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Pharmacological Efficacy and Safety Profile of Taranabant in Preclinical Species
T. M. Fong et al.
DRUG DEVELOPMENT RESEARCH (2009)
Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke
Ming Zhang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
The enigmatic pharmacology of GPR55
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Effects of Δ9-tetrahydrocannabivarin on [35S] GTPγS binding in mouse brain cerebellum and piriform cortex membranes
I. Dennis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The phytocannabinoid Δ9-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum
Y-L Ma et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers
B. Bingham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The psychoactive plant cannabinoid, Delta(9)-tetrahydrocannabinol, is antagonized by Delta(8)- and Delta(9)-tetrahydrocannabivarin in mice in vivo
R. G. Pertwee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors
S. Maione et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors
A. Scutt et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases
Ariane Mallat et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists
G. T. Whiteside et al.
CURRENT MEDICINAL CHEMISTRY (2007)
In vitro pharmacological characterization of AM1241:: a protean agonist at the cannabinoid CB2 receptor?
B. B. Yao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist
Fumimasa Amaya et al.
PAIN (2006)
Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist
A Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw
B Costa et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
mu opioid receptor signaling in morphine sensitization
D Vigano et al.
NEUROSCIENCE (2003)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Inverse, protean, and ligand-selective agonism: matters of receptor conformation
T Kenakin
FASEB JOURNAL (2001)
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
NE Buckley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
